45. Spotlight on Special Topics: Shared Decision Making 1372-268

1372-268 - COST-BENEFIT ASSESSMENT IN PATIENTS WITH A CLINICAL INDICATION FOR PCSK9 INHIBITORS ACCORDING TO MEDICATION USE AND CLINICAL EVENT STATUS

Session
1372 - Spotlight on Special Topics: Shared Decision Making 6
Speakers
Pathway
45. Spotlight on Special Topics: Shared Decision Making
Presentation Number
1372-268
Presentation Rating
 |